Dow 30 Stock Roundup: NIKE Beats Estimates, Pfizer Ups 2015 Outlook, Microsoft Changes Reporting Structure

By | October 2, 2015
0 Comment

Scalper1 News

The Dow experienced a mixed week as gains were again limited by concerns from China and a slump in biotech stocks. The blue chip index declined on Monday following a continuing slump in biotech stocks and weak data coming Scalper1 News

Scalper1 News

Related posts:

  1. Dow 30 Stock Roundup: Chevron, ExxonMobil Post Dismal Results, Microsoft's Windows 10 Impresses – Analyst Blog
  2. Dow 30 Stock Roundup: Boeing Posts Strong Delivery Numbers, Microsoft to Sack 7.8K Employees – Analyst Blog
  3. Dow 30 Stock Roundup: Microsoft Hikes Dividend, Apple Delays WatchOS 2 Launch
  4. Dow 30 Stock Roundup: Pfizer Drug Trial Dents, P&G Ups Dividend – Analyst Blog